Survey of Ophthalmology
Volume 44, Supplement 2 , Pages S155-S162, January 2000

The Efficacy and Safety of Brinzolamide 1% Ophthalmic Suspension (Azopt®) as a Primary Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension☆☆☆

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was funded by Alcon Research, Ltd.

☆☆ Dr. Sall has no commercial or proprietary interest in the products and concepts discussed in this article.

PII: S0039-6257(99)00107-1

Survey of Ophthalmology
Volume 44, Supplement 2 , Pages S155-S162, January 2000

Article Tools